Food Allergy: From Primary Prevention to Treatment and Intervention
This meeting is sold out. No onsite registrations will be taken.
Check here to order recordings of the program.
This live course will allow participants to increase their knowledge and skills related to the diagnosis and management of food allergic patients. It will highlight the latest evidence related to food allergies, and will include a combination of lectures, small group discussions, and hands-on training to prepare participants to return to their practices prepared to provide optimal care to these patients.
Registration Fees
Attendee Type | Advance Fee (Through Aug. 23) |
---|---|
AAAAI Member Physician | $395 |
Fellow-in-Training, Resident, Student | $50 |
Nurse, Nurse Practitioner, Physician Assistant, other Allied Health Practitioner | $100 |
Non-Member Physician | $495 |
Cancellations & Refunds
Registration fees will be refunded in full for cancellations made on or before Thursday, August 29, 2019. Cancellations made after this date are not eligible for a refund. Please contact cme@aaaai.org with questions regarding cancellations and refunds.
Target Audience
- Practicing physicians (A/I specialists and others who treat food-allergic patients)
- Fellows-in-training
- Nurses
- Nurse Practitioners
- Physician Assistants
- Allied Health practitioners
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply evidence-based decision making to the diagnosis of food allergic patients
- Translate into practice the approved guidelines for food allergy prevention
- Implement effective education strategies related to the prevention and treatment of anaphylaxis
- Identify and apply the treatment options currently available for patients with food allergies
Sponsorship Opportunities
Please click the Sponsorship Prospectus and Sponsorship Floorplan documents, below, for information about sponsorship opportunities for this meeting.
Additional Information
Attachment | Size |
---|---|
Accessing Handouts & Claiming Credit | 157.97 KB |
Non-CME Educational Programs | 52.51 KB |
Food Allergy Agenda | 284.98 KB |
Date | Start Time | End Time | Name |
9/6/2019 | 1:00 PM | 6:00 PM | Overview of Food Allergy Diagnosis and Management |
1:00 PM | 6:00 PM | Lectures on Overview of Food Allergy Diagnosis and Management | |
1:00 PM | 1:40 PM | Epidemiology & Natural History of Food Allergy w/ Q&A | |
1:40 PM | 2:20 PM | Pathophysiology of Food Allergy w/ Q&A | |
2:20 PM | 3:00 PM | Food Allergy Cases: Clinical Presentations of Food Allergy w/ Q&A | |
3:00 PM | 3:40 PM | Food Allergy Cases: Approach to Diagnosis and Management w/ Q&A | |
3:40 PM | 4:00 PM | Break | |
4:00 PM | 4:40 PM | Optimal Use Diagnostic Testing: Components and Oral Food Challenges w/ Q&A | |
4:40 PM | 5:20 PM | Anaphylaxis: Prevention and Management w/ Q&A | |
5:20 PM | 6:00 PM | Panel Discussion | |
9/7/2019 | 8:00 AM | 5:15 PM | Overview of Specific Syndromes |
8:00 AM | 10:00 AM | Lectures on Specific Syndromes | |
8:00 AM | 8:40 AM | Nuts and Bolts of Atopic Dermatitis w/ Q&A | |
8:40 AM | 9:20 AM | Non IgE Mediated Food Allergy w/ Q&A | |
9:20 AM | 10:00 AM | Eosinophilic Esophagitis: Optimal Diagnosis and Management w/ Q&A | |
10:00 AM | 10:15 AM | Break | |
10:15 AM | 11:00 AM | Hands-on and Discussion Breakouts | |
What do I need to know? Performing Oral Food Challenges in the Office Setting | |||
Anaphylaxis Management in Different Settings | |||
Case Based Approach to Testing for Food Allergy | |||
Patterns of Cross-Reactivity in Food Allergy | |||
Risk Management in Oral Food Challenges | |||
Avoidance Diets & Nutrition | |||
Essentials of Education for Patients | |||
11:00 AM | 11:15 AM | Break | |
11:15AM | 12:00 PM | Hands-on and Discussion Breakouts | |
Oral Food Challenges in the Office Setting | |||
Anaphylaxis Management in Different Settings | |||
Case Based Approach to Testing for Food Allergy | |||
Atopic Dermatitis: Optimal Management and the Role of Food Allergy | |||
Risk Management in Oral Food Challenges | |||
Avoidance Diets & Nutrition | |||
Essentials of Education for Patients | |||
12:00 PM | 1:30 PM | Break | |
1:45 PM | 3:45 PM | Lectures on the Treatment of Food Allergy | |
1:45 PM | 2:25 PM | Oral Immunotherapy: Integration into Clinical Practice w/ Q&A | |
2:25 PM | 2:50 PM | Epicutaneous Immunotherapy w/ Q&A | |
2:50 PM | 3:10 PM | The Role of Omalizumab in Food Allergy w/ Q&A | |
3:10 PM | 3:30 PM | Phase I and Phase II Clinical Trials Moving Through FDA Process w/ Q&A | |
3:30 PM | 3:45 PM | Panel Discussion | |
3:45 PM | 4:00 PM | Break | |
4:00 PM | 4:45 PM | Discussion Breakouts | |
4:00 PM | 4:45 PM | Epicutaneous and Other Treatment Approaches | |
4:00 PM | 4:45 PM | Oral Immunotherapy | |
4:00 PM | 4:45 PM | What Happens After the Research Study? | |
4:00 PM | 4:45 PM | Avoidance Diets for Atopic Dermatitis and EOE | |
4:00 PM | 4:45 PM | Introduction of Baked Milk and Egg | |
4:00 PM | 4:45 PM | Future Diagnostic Testing | |
4:45 PM | 5:00 PM | Break | |
5:00 PM | 5:45 PM | Discussion Breakouts | |
5:00 PM | 5:45 PM | The Use of Biologics in Food Allergy | |
5:00 PM | 5:45 PM | Oral Immunotherapy | |
5:00 PM | 5:45 PM | Introduction of Baked Milk and Egg | |
5:00 PM | 5:45 PM | Complimentary Medicine and Non-Traditional Approaches to Food Allergy Treatment | |
5:00 PM | 5:45 PM | Management of Severe Atopic Dermatitis | |
9/8/2019 | 8:00 AM | 12:45 PM | Novel Research & Prevention of Food Allergy |
8:00 AM | 10:00 AM | Lectures on Novel Research and Prevention of Food Allergy | |
8:00 AM | 8:40 AM | Prevention of Peanut Allergy w/ Q&A | |
8:40 AM | 9:20 AM | Prevention of Food Allergy: Beyond Peanut w/ Q&A | |
9:20 AM | 9:40 AM | Taking this course back to the clinic | |
9:40 AM | 10:00 AM | Panel Discussion | |
10:00 AM | 10:30 AM | Break | |
10:30 AM | 11:30 AM | Discussion Breakouts | |
10:30 AM | 11:30 AM | Food Allergy Research in the Office Setting | |
10:30 AM | 11:30 AM | Logistics of Early Introduction of Peanut and Other Foods | |
10:30 AM | 11:30 AM | Future Directions in Food Allergy Prevention | |
10:30 AM | 11:30 AM | Future Directions in Food Allergy Treatment | |
10:30 AM | 11:30 AM | Food Allergy in Adults: Is Anything different? |
Housing
The AAAAI has reserved room blocks at the following hotels for your convenience:
Hilton Chicago (all events take place in this facility)
Discounted rate of $189/night + tax
Reservation deadline: Friday, August 16, 2019
Online reservations: https://book.passkey.com/go/AAAAI2019
Phone reservations: (312) 922-4400 – Please reference code “AFA” to receive the AAAAI discounted rate.
The Blackstone (approximately a 1 block walk)
Discounted rate of $249/night + tax
Reservation deadline: Thursday, August 8, 2019
Online reservations: https://www.marriott.com/event-reservations/reservation-link.mi?id=1556833021201&key=GRP&app=resvlink
Phone reservations: (800) 505-0261 or (312) 447-0955 – Please reference group code “AAAAI” to receive the AAAAI discounted rate.
All reservations are subject to availability and are on a first-come, first-serve basis.
Planning Committee
Robert Wood, MD FAAAAI
Johns Hopkins University School of Medicine, Baltimore, MD
Relevant relationships: Aimmune (research grant); Astellas (research grant); DBV Technologies (research grant); HAL-Allergy (research grant); Sanofi (research grant); Regeneron (research grant)
Ashley Devonshire, MD
Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
Relevant relationships: None
Kim Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None
Lily Pien, MD FAAAAI
Cleveland Clinic Foundation, Cleveland, OH
Relevant relationships: None
Yamini Virkud, MD
Massachusetts General Hospital, Boston, MA
Relevant relationships: None
Speaking Faculty
Cecilia Berin, PhD
Mount Sinai School of Medcine, New York City, NY
Relevant relationships: ProtaTherapeutics (advisory board)
J. Andrew Bird, MD FAAAAI
University of Texas Southwestern Medical Center, Dallas, TX
Relevant relationships: DBV Technologies (advisory board, speaker, research grant); Aimmune Therapeutics (advisory board); Pfizer (advisory board); Pharm Olam International (data & safety monitoring board)
Christina Ciaccio, MD FAAAAI
University of Chicago, Chicago, IL
Relevant relationships: Regeneron (advisory board); Aimmune (speaker)
David Fleischer, MD FAAAAI
University of Colorado Medicine/Children’s Hospital Colorado, Aurora, CO
Relevant relationships: Aquestive (consultant); INSYS Therapeutics, Inc. (consultant); AllerGenis (consultant); Nutricia (speaker); Abbott (speaker); Aimmune Therapeutics (research grant); DBV Technologies (consultant, advisory board, research grant)
Marion Groetch, MS RDN
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: Nutricia North America (speaker); Mead Johnson (speaker); Abbott (speaker)
Anne Hiegel, APRN
University of Arkansas Medical School/Arkansas Children’s Hospital, Little Rock, AR
Relevant relationships: None
Jackie Isola, RN MS CPNP
Johns Hopkins Hospital, Baltimore, MD
Relevant relationships: None
Stacie Jones, MD
University of Arkansas Medical School/Arkansas Children’s Hospital, Little Rock, AR
Relevant relationships: Aimmune Therapeutics (advisory board, clinical trials); Sanofi, Inc. (clinical trials); DBV Technologies (clinical trials); Astellas, Inc. (clinical trials)
Corinne Keet, MD MS PhD
Johns Hopkins School of Medicine, Baltimore, MD
Relevant relationships: None
John Kelso, MD FAAAAI
Scripps Clinic, San Diego, CA
Relevant relationships: None
Donald Leung, MD PhD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Abbvie (advisory board); Aimmune (advisory board); Incyte (advisory board); Novartis (advisory board); Regeneron (advisory board); Sanofi (advisory board); Pfizer (research grant)
Emily McGowan, MD PhD FAAAAI
University of Virginia School of Medicine, Charlottesville, VA
Relevant relationships: Shire (consultant)
Kim Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None
Sally Noone, RN MSN
Retired
Relevant relationships: None
Anna Nowak-Wegrzyn, MD PhD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: Merck (advisory board); Abbott (speaker); Mead Johnson (speaker); Gerber (advisory board); Alk Abello (clinical trials); Labcorp (advisory board); Astellas (research grant); DBV Technologies (research grant)
Wayne Shreffler, MD PhD FAAAAI
Massachusetts General Hospital, Boston, MA
Relevant relationships: None
Scott Sicherer, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: HAL Allergy (research grant)
Jonathan Spergel, MD PhD FAAAAI
Children’s Hospital of Philadelphia, Philadelphia, PA
Relevant relationships: DBV Technologies (advisory board); Regeneron (consultant)
Pamela Steele, MSN CPNP AE-C
University of North Carolina at Chapel Hill Health Care, Chapel Hill, NC
Relevant relationships: None
Carina Venter, PhD RD
University of Colorado/Children’s Hospital Colorado, Aurora, CO
Relevant relationships: Danone (speaker); Mead Johnson (speaker); Nestle (speaker); DBV Technologies (advisory board); Abbott (speaker); Thermo Fisher (research grant)
Brian Vickery, MD FAAAAI
Emory University, Atlanta, GA
Relevant relationships: Thermo Fisher (speaker); Aimmune (advisory board)
Julie Wang, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: JDP Therapeutics (advisory board); Aimmune (consultant); DBV Technologies (advisory board)
Robert Wood, MD FAAAAI
Johns Hopkins University School of Medicine, Baltimore, MD
Relevant relationships: Aimmune (research grant); Astellas (research grant); DBV Technologies (research grant); HAL-Allergy (research grant); Sanofi (research grant); Regeneron (research grant)
Content Reviewers
Anne Borgmeyer, RN CPNP AE-C
St. Louis Childrens Hospital, St. Louis, MO
Relevant relationships: None
Brian Kelly, MD
St. Paul Allergy and Asthma, St. Paul, MN
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 14.50 Contact Hours.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on June 30, 2020. Requests to claim credit on or after July 1, 2020 will be subject to an administrative fee.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Questions
Activity-related questions should be directed to Deborah Levinson (cme@aaaai.org).
Registration and credit claiming questions should be directed to cme@aaaai.org.
Available Credit
- 14.50 AttendanceAttendance credit.
- 14.50 CECE credit.
- 14.50 CMECME credit.
Price
REGISTRATION CLOSED. THIS MEETING IS SOLD OUT. NO ONSITE REGISTRATIONS WILL BE TAKEN.
PLEASE CLICK HERE FOR INFORMATION ABOUT PRE-ORDERING RECORDINGS OF THIS PROGRAM.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.
Internet Explorer is no longer supported.